280 related articles for article (PubMed ID: 17638895)
21. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.
Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T
Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
Wang Q; Sun Z; Yang HS
Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
[TBL] [Abstract][Full Text] [Related]
23. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
[TBL] [Abstract][Full Text] [Related]
24. Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line.
Park CH; Hahm ER; Lee JH; Jung KC; Rhee HS; Yang CH
Carcinogenesis; 2005 Nov; 26(11):1929-33. PubMed ID: 15930030
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of fascin1 expression suppresses the proliferation and metastasis of gastric cancer cells.
Fu H; Wen JF; Hu ZL; Luo GQ; Ren HZ
Pathology; 2009; 41(7):655-60. PubMed ID: 20001345
[TBL] [Abstract][Full Text] [Related]
26. TGF-β1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways.
Yang J; Zhang N; Gao R; Zhu Y; Zhang Z; Xu X; Wang J; Li Z; Liu X; Li Z; Li J; Bi J; Kong C
Biochem Biophys Res Commun; 2018 Jul; 501(4):913-919. PubMed ID: 29772238
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional activation of the beta-catenin gene at the invasion front of colorectal liver metastases.
Bandapalli OR; Dihlmann S; Helwa R; Macher-Goeppinger S; Weitz J; Schirmacher P; Brand K
J Pathol; 2009 Jul; 218(3):370-9. PubMed ID: 19347947
[TBL] [Abstract][Full Text] [Related]
28. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.
Duquet A; Melotti A; Mishra S; Malerba M; Seth C; Conod A; Ruiz i Altaba A
EMBO Mol Med; 2014 Jul; 6(7):882-901. PubMed ID: 24920608
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of fascin-1 is involved in HIF-1α-dependent invasion and migration of hypopharyngeal squamous cell carcinoma.
Bu M; Liu X; Liu X; Xu W
Int J Oncol; 2019 Aug; 55(2):488-498. PubMed ID: 31268159
[TBL] [Abstract][Full Text] [Related]
30. DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.
He TY; Wu DW; Lin PL; Wang L; Huang CC; Chou MC; Lee H
Sci Rep; 2016 Feb; 6():21483. PubMed ID: 26892600
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.
Li C; Liu J; Zhang Q; Cui K; Ge Q; Wang C; Chen Z
Int J Oncol; 2018 Jun; 52(6):1815-1826. PubMed ID: 29620261
[TBL] [Abstract][Full Text] [Related]
32. WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer.
Yoshikawa H; Matsubara K; Zhou X; Okamura S; Kubo T; Murase Y; Shikauchi Y; Esteller M; Herman JG; Wei Wang X; Harris CC
Mol Biol Cell; 2007 Nov; 18(11):4292-303. PubMed ID: 17761539
[TBL] [Abstract][Full Text] [Related]
33. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
[TBL] [Abstract][Full Text] [Related]
34. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
Takahashi M; Nakamura Y; Obama K; Furukawa Y
Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
[TBL] [Abstract][Full Text] [Related]
35. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
Gavert N; Conacci-Sorrell M; Gast D; Schneider A; Altevogt P; Brabletz T; Ben-Ze'ev A
J Cell Biol; 2005 Feb; 168(4):633-42. PubMed ID: 15716380
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
37. TGF-β1 promotes the migration and invasion of bladder carcinoma cells by increasing fascin1 expression.
Zhang N; Bi X; Zeng Y; Zhu Y; Zhang Z; Liu Y; Wang J; Li X; Bi J; Kong C
Oncol Rep; 2016 Aug; 36(2):977-83. PubMed ID: 27350089
[TBL] [Abstract][Full Text] [Related]
38. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
39. Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity.
Li N; Lee K; Xi Y; Zhu B; Gary BD; Ramírez-Alcántara V; Gurpinar E; Canzoneri JC; Fajardo A; Sigler S; Piazza JT; Chen X; Andrews J; Thomas M; Lu W; Li Y; Laan DJ; Moyer MP; Russo S; Eberhardt BT; Yet L; Keeton AB; Grizzle WE; Piazza GA
Oncogene; 2015 Mar; 34(12):1499-509. PubMed ID: 24704829
[TBL] [Abstract][Full Text] [Related]
40. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3.
Pendás-Franco N; García JM; Peña C; Valle N; Pálmer HG; Heinäniemi M; Carlberg C; Jiménez B; Bonilla F; Muñoz A; González-Sancho JM
Oncogene; 2008 Jul; 27(32):4467-77. PubMed ID: 18408752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]